A comparison piece weighing the two leading GLP-1 drugs against each other. Only the title came through, so details are unknown.
Recap by typeshit. Full story at Philstar Life.
The $49 virtual weight management visits now cover insurance checks and Medicare GLP-1 Bridge support, with pharmacists contacting everyone who starts a fill.
A press release announces Woodward's new book, which she says debunks common peptide myths aimed at women. No other details were given.
A local feature on clinics in Sarasota using peptides for recovery, hormones and wellness. The claims come from the practitioners and are not backed by cited evidence.
Endpoints News
The Copenhagen drugmaker has a slate of weight loss candidates but says its future depends on building a much wider pipeline.
Alicia Butterfield claims Anthem denied her Zepbound once the drug got her below morbid obesity. A Los Angeles judge stayed her case pending arbitration.
A sponsored-style look at compounded tirzepatide and semaglutide through telehealth firm Mochi Health, noting compounded drugs aren't FDA approved for safety or quality.
Loading…